Harmony Biosciences Holdings (HRMY) Short-term Investments (2022 - 2026)

Harmony Biosciences Holdings (HRMY) has 5 years of Short-term Investments data on file, last reported at $51.5 million in Q1 2026.

• For the quarter ending Q1 2026, Short-term Investments rose 186.94% year-over-year to $51.5 million; the trailing twelve-month figure through Mar 2026 stood at $51.5 million (up 186.94% YoY), and the FY2025 full-year result was $22.8 million, up 61.0% from the prior year.
• Short-term Investments advanced to $51.5 million in Q1 2026, from $22.8 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $79.3 million in Q4 2022 to a low of $14.2 million in Q4 2024.
• A 5-year average of $36.5 million and a median of $34.5 million in 2024 frame the typical range for Short-term Investments.
• Across the five-year window, Short-term Investments jumped 203.71% in 2023 and sank 66.06% in 2024, its largest moves.
• Tracing HRMY's Short-term Investments over 5 years: stood at $79.3 million in 2022, then slumped by 47.31% to $41.8 million in 2023, then slumped by 66.06% to $14.2 million in 2024, then soared by 61.0% to $22.8 million in 2025, then surged by 125.59% to $51.5 million in 2026.
• Business Quant data shows HRMY's Short-term Investments at $51.5 million in Q1 2026, $22.8 million in Q4 2025, and $25.6 million in Q3 2025.